New drug duo aims to tame resistant blood cancers
Disease control
Recruiting now
This study is testing if adding the drug ruxolitinib to the immunotherapy pembrolizumab is safe and can help control several types of lymphoma that have returned or resisted standard chemotherapy. It is for adults with specific T-cell or B-cell lymphomas who have tried at least o…
Phase: PHASE2 • Sponsor: Seda S. Tolu • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC